nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1B—dura mater—ankylosing spondylitis	0.209	0.445	CbGeAlD
Methysergide—HTR1D—dura mater—ankylosing spondylitis	0.203	0.431	CbGeAlD
Methysergide—HTR2A—vertebral column—ankylosing spondylitis	0.0302	0.0643	CbGeAlD
Methysergide—Telangiectasia—Methylprednisolone—ankylosing spondylitis	0.0259	0.0489	CcSEcCtD
Methysergide—Telangiectasia—Dexamethasone—ankylosing spondylitis	0.0236	0.0445	CcSEcCtD
Methysergide—Telangiectasia—Betamethasone—ankylosing spondylitis	0.0236	0.0445	CcSEcCtD
Methysergide—Telangiectasia—Prednisone—ankylosing spondylitis	0.0205	0.0387	CcSEcCtD
Methysergide—Telangiectasia—Methotrexate—ankylosing spondylitis	0.0172	0.0324	CcSEcCtD
Methysergide—Mydriasis—Prednisolone—ankylosing spondylitis	0.00835	0.0158	CcSEcCtD
Methysergide—SIGMAR1—tendon—ankylosing spondylitis	0.00821	0.0175	CbGeAlD
Methysergide—HTR2B—tendon—ankylosing spondylitis	0.00819	0.0174	CbGeAlD
Methysergide—HTR7—tendon—ankylosing spondylitis	0.00701	0.0149	CbGeAlD
Methysergide—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00572	0.0108	CcSEcCtD
Methysergide—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.00559	0.0105	CcSEcCtD
Methysergide—Pleural effusion—Methotrexate—ankylosing spondylitis	0.00528	0.00996	CcSEcCtD
Methysergide—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00526	0.00993	CcSEcCtD
Methysergide—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00525	0.0099	CcSEcCtD
Methysergide—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.00514	0.00969	CcSEcCtD
Methysergide—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.00512	0.00967	CcSEcCtD
Methysergide—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00477	0.00901	CcSEcCtD
Methysergide—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00477	0.00901	CcSEcCtD
Methysergide—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.00466	0.00879	CcSEcCtD
Methysergide—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.00466	0.00879	CcSEcCtD
Methysergide—Oliguria—Methotrexate—ankylosing spondylitis	0.00439	0.00828	CcSEcCtD
Methysergide—HTR2A—tendon—ankylosing spondylitis	0.00437	0.00931	CbGeAlD
Methysergide—Euphoric mood—Prednisone—ankylosing spondylitis	0.00416	0.00784	CcSEcCtD
Methysergide—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00406	0.00765	CcSEcCtD
Methysergide—Weight increased—Prednisolone—ankylosing spondylitis	0.0038	0.00717	CcSEcCtD
Methysergide—Urine output increased—Methotrexate—ankylosing spondylitis	0.00366	0.0069	CcSEcCtD
Methysergide—Weight increased—Triamcinolone—ankylosing spondylitis	0.0035	0.0066	CcSEcCtD
Methysergide—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00349	0.00658	CcSEcCtD
Methysergide—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00339	0.0064	CcSEcCtD
Methysergide—Polyuria—Methotrexate—ankylosing spondylitis	0.00334	0.00631	CcSEcCtD
Methysergide—Weight increased—Betamethasone—ankylosing spondylitis	0.00317	0.00598	CcSEcCtD
Methysergide—Weight increased—Dexamethasone—ankylosing spondylitis	0.00317	0.00598	CcSEcCtD
Methysergide—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00315	0.00595	CcSEcCtD
Methysergide—Weight decreased—Betamethasone—ankylosing spondylitis	0.00315	0.00595	CcSEcCtD
Methysergide—Neutropenia—Prednisone—ankylosing spondylitis	0.00284	0.00536	CcSEcCtD
Methysergide—Weight increased—Prednisone—ankylosing spondylitis	0.00276	0.00521	CcSEcCtD
Methysergide—Ataxia—Methotrexate—ankylosing spondylitis	0.00276	0.00521	CcSEcCtD
Methysergide—Weight decreased—Prednisone—ankylosing spondylitis	0.00275	0.00518	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.0027	0.0051	CcSEcCtD
Methysergide—Malaise—Prednisolone—ankylosing spondylitis	0.00263	0.00495	CcSEcCtD
Methysergide—Back pain—Triamcinolone—ankylosing spondylitis	0.00259	0.00488	CcSEcCtD
Methysergide—Convulsion—Prednisolone—ankylosing spondylitis	0.00252	0.00476	CcSEcCtD
Methysergide—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00251	0.00474	CcSEcCtD
Methysergide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00248	0.00469	CcSEcCtD
Methysergide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00248	0.00468	CcSEcCtD
Methysergide—Alopecia—Betamethasone—ankylosing spondylitis	0.00247	0.00465	CcSEcCtD
Methysergide—Alopecia—Dexamethasone—ankylosing spondylitis	0.00247	0.00465	CcSEcCtD
Methysergide—Discomfort—Prednisolone—ankylosing spondylitis	0.00245	0.00462	CcSEcCtD
Methysergide—Malaise—Triamcinolone—ankylosing spondylitis	0.00241	0.00455	CcSEcCtD
Methysergide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00241	0.00454	CcSEcCtD
Methysergide—Oedema—Prednisolone—ankylosing spondylitis	0.00238	0.00448	CcSEcCtD
Methysergide—Dysuria—Methotrexate—ankylosing spondylitis	0.00237	0.00448	CcSEcCtD
Methysergide—Neutropenia—Methotrexate—ankylosing spondylitis	0.00237	0.00448	CcSEcCtD
Methysergide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00232	0.00438	CcSEcCtD
Methysergide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00232	0.00437	CcSEcCtD
Methysergide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00231	0.00437	CcSEcCtD
Methysergide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00228	0.0043	CcSEcCtD
Methysergide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00227	0.00429	CcSEcCtD
Methysergide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00227	0.00429	CcSEcCtD
Methysergide—Drowsiness—Methotrexate—ankylosing spondylitis	0.00226	0.00427	CcSEcCtD
Methysergide—Flushing—Prednisone—ankylosing spondylitis	0.00226	0.00425	CcSEcCtD
Methysergide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00225	0.00425	CcSEcCtD
Methysergide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00225	0.00425	CcSEcCtD
Methysergide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00225	0.00425	CcSEcCtD
Methysergide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00225	0.00424	CcSEcCtD
Methysergide—Malaise—Dexamethasone—ankylosing spondylitis	0.00219	0.00413	CcSEcCtD
Methysergide—Malaise—Betamethasone—ankylosing spondylitis	0.00219	0.00413	CcSEcCtD
Methysergide—Oedema—Triamcinolone—ankylosing spondylitis	0.00219	0.00412	CcSEcCtD
Methysergide—Insomnia—Prednisolone—ankylosing spondylitis	0.00215	0.00405	CcSEcCtD
Methysergide—Alopecia—Prednisone—ankylosing spondylitis	0.00215	0.00405	CcSEcCtD
Methysergide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00213	0.00402	CcSEcCtD
Methysergide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00213	0.00402	CcSEcCtD
Methysergide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00213	0.00401	CcSEcCtD
Methysergide—Convulsion—Betamethasone—ankylosing spondylitis	0.0021	0.00397	CcSEcCtD
Methysergide—Convulsion—Dexamethasone—ankylosing spondylitis	0.0021	0.00397	CcSEcCtD
Methysergide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00207	0.0039	CcSEcCtD
Methysergide—Myalgia—Betamethasone—ankylosing spondylitis	0.00207	0.0039	CcSEcCtD
Methysergide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00204	0.00385	CcSEcCtD
Methysergide—Discomfort—Betamethasone—ankylosing spondylitis	0.00204	0.00385	CcSEcCtD
Methysergide—Pain—Prednisolone—ankylosing spondylitis	0.00203	0.00383	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00199	0.00376	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00199	0.00375	CcSEcCtD
Methysergide—Oedema—Dexamethasone—ankylosing spondylitis	0.00198	0.00374	CcSEcCtD
Methysergide—Oedema—Betamethasone—ankylosing spondylitis	0.00198	0.00374	CcSEcCtD
Methysergide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00198	0.00373	CcSEcCtD
Methysergide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00197	0.00372	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00196	0.0037	CcSEcCtD
Methysergide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00196	0.0037	CcSEcCtD
Methysergide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00196	0.00369	CcSEcCtD
Methysergide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00196	0.00369	CcSEcCtD
Methysergide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00195	0.00367	CcSEcCtD
Methysergide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00194	0.00366	CcSEcCtD
Methysergide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00194	0.00366	CcSEcCtD
Methysergide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00194	0.00365	CcSEcCtD
Methysergide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00194	0.00365	CcSEcCtD
Methysergide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00192	0.00363	CcSEcCtD
Methysergide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00192	0.00362	CcSEcCtD
Methysergide—Malaise—Prednisone—ankylosing spondylitis	0.00191	0.0036	CcSEcCtD
Methysergide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00188	0.00355	CcSEcCtD
Methysergide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00188	0.00355	CcSEcCtD
Methysergide—Pain—Triamcinolone—ankylosing spondylitis	0.00187	0.00352	CcSEcCtD
Methysergide—Convulsion—Prednisone—ankylosing spondylitis	0.00183	0.00346	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00181	0.00341	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00181	0.00341	CcSEcCtD
Methysergide—Arthralgia—Prednisone—ankylosing spondylitis	0.0018	0.0034	CcSEcCtD
Methysergide—Myalgia—Prednisone—ankylosing spondylitis	0.0018	0.0034	CcSEcCtD
Methysergide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0018	0.0034	CcSEcCtD
Methysergide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0018	0.00339	CcSEcCtD
Methysergide—Alopecia—Methotrexate—ankylosing spondylitis	0.00179	0.00339	CcSEcCtD
Methysergide—Insomnia—Betamethasone—ankylosing spondylitis	0.00179	0.00338	CcSEcCtD
Methysergide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00179	0.00338	CcSEcCtD
Methysergide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00178	0.00336	CcSEcCtD
Methysergide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00178	0.00336	CcSEcCtD
Methysergide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00178	0.00336	CcSEcCtD
Methysergide—Discomfort—Prednisone—ankylosing spondylitis	0.00178	0.00336	CcSEcCtD
Methysergide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00175	0.00329	CcSEcCtD
Methysergide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00175	0.00329	CcSEcCtD
Methysergide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00173	0.00326	CcSEcCtD
Methysergide—Oedema—Prednisone—ankylosing spondylitis	0.00173	0.00326	CcSEcCtD
Methysergide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00172	0.00325	CcSEcCtD
Methysergide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00171	0.00323	CcSEcCtD
Methysergide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00171	0.00323	CcSEcCtD
Methysergide—Back pain—Methotrexate—ankylosing spondylitis	0.00171	0.00323	CcSEcCtD
Methysergide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00171	0.00322	CcSEcCtD
Methysergide—Fatigue—Betamethasone—ankylosing spondylitis	0.00171	0.00322	CcSEcCtD
Methysergide—Pain—Dexamethasone—ankylosing spondylitis	0.0017	0.0032	CcSEcCtD
Methysergide—Pain—Betamethasone—ankylosing spondylitis	0.0017	0.0032	CcSEcCtD
Methysergide—Tachycardia—Prednisone—ankylosing spondylitis	0.00169	0.00318	CcSEcCtD
Methysergide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00309	CcSEcCtD
Methysergide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00163	0.00308	CcSEcCtD
Methysergide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00163	0.00308	CcSEcCtD
Methysergide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00162	0.00306	CcSEcCtD
Methysergide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00162	0.00306	CcSEcCtD
Methysergide—Malaise—Methotrexate—ankylosing spondylitis	0.00159	0.00301	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00157	0.00297	CcSEcCtD
Methysergide—Dizziness—Prednisolone—ankylosing spondylitis	0.00157	0.00296	CcSEcCtD
Methysergide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00157	0.00296	CcSEcCtD
Methysergide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00157	0.00296	CcSEcCtD
Methysergide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00157	0.00296	CcSEcCtD
Methysergide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00157	0.00296	CcSEcCtD
Methysergide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00157	0.00296	CcSEcCtD
Methysergide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00156	0.00295	CcSEcCtD
Methysergide—Insomnia—Prednisone—ankylosing spondylitis	0.00156	0.00295	CcSEcCtD
Methysergide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00155	0.00292	CcSEcCtD
Methysergide—Convulsion—Methotrexate—ankylosing spondylitis	0.00153	0.00289	CcSEcCtD
Methysergide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00152	0.00287	CcSEcCtD
Methysergide—Chest pain—Methotrexate—ankylosing spondylitis	0.00151	0.00284	CcSEcCtD
Methysergide—Arthralgia—Methotrexate—ankylosing spondylitis	0.00151	0.00284	CcSEcCtD
Methysergide—Myalgia—Methotrexate—ankylosing spondylitis	0.00151	0.00284	CcSEcCtD
Methysergide—Rash—Prednisolone—ankylosing spondylitis	0.0015	0.00283	CcSEcCtD
Methysergide—Dermatitis—Prednisolone—ankylosing spondylitis	0.0015	0.00282	CcSEcCtD
Methysergide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00149	0.00281	CcSEcCtD
Methysergide—Fatigue—Prednisone—ankylosing spondylitis	0.00149	0.00281	CcSEcCtD
Methysergide—Discomfort—Methotrexate—ankylosing spondylitis	0.00149	0.00281	CcSEcCtD
Methysergide—Constipation—Prednisone—ankylosing spondylitis	0.00148	0.00279	CcSEcCtD
Methysergide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00145	0.00273	CcSEcCtD
Methysergide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00144	0.00272	CcSEcCtD
Methysergide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00142	0.00268	CcSEcCtD
Methysergide—Asthenia—Betamethasone—ankylosing spondylitis	0.00142	0.00268	CcSEcCtD
Methysergide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00142	0.00268	CcSEcCtD
Methysergide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00141	0.00266	CcSEcCtD
Methysergide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00141	0.00266	CcSEcCtD
Methysergide—Nausea—Prednisolone—ankylosing spondylitis	0.00141	0.00266	CcSEcCtD
Methysergide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00139	0.00262	CcSEcCtD
Methysergide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00139	0.00261	CcSEcCtD
Methysergide—Rash—Triamcinolone—ankylosing spondylitis	0.00138	0.0026	CcSEcCtD
Methysergide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00138	0.0026	CcSEcCtD
Methysergide—Rash—Methylprednisolone—ankylosing spondylitis	0.00137	0.00259	CcSEcCtD
Methysergide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00137	0.00259	CcSEcCtD
Methysergide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00137	0.00257	CcSEcCtD
Methysergide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00137	0.00257	CcSEcCtD
Methysergide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00136	0.00256	CcSEcCtD
Methysergide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00136	0.00256	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00131	0.00248	CcSEcCtD
Methysergide—Dizziness—Betamethasone—ankylosing spondylitis	0.00131	0.00247	CcSEcCtD
Methysergide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00131	0.00247	CcSEcCtD
Methysergide—Insomnia—Methotrexate—ankylosing spondylitis	0.00131	0.00246	CcSEcCtD
Methysergide—Nausea—Triamcinolone—ankylosing spondylitis	0.0013	0.00245	CcSEcCtD
Methysergide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.0013	0.00244	CcSEcCtD
Methysergide—Nausea—Methylprednisolone—ankylosing spondylitis	0.0013	0.00244	CcSEcCtD
Methysergide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00129	0.00243	CcSEcCtD
Methysergide—Somnolence—Methotrexate—ankylosing spondylitis	0.00128	0.00242	CcSEcCtD
Methysergide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00127	0.0024	CcSEcCtD
Methysergide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00126	0.00238	CcSEcCtD
Methysergide—Vomiting—Betamethasone—ankylosing spondylitis	0.00126	0.00238	CcSEcCtD
Methysergide—Rash—Betamethasone—ankylosing spondylitis	0.00125	0.00236	CcSEcCtD
Methysergide—Rash—Dexamethasone—ankylosing spondylitis	0.00125	0.00236	CcSEcCtD
Methysergide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00125	0.00236	CcSEcCtD
Methysergide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00125	0.00236	CcSEcCtD
Methysergide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00125	0.00235	CcSEcCtD
Methysergide—Fatigue—Methotrexate—ankylosing spondylitis	0.00124	0.00235	CcSEcCtD
Methysergide—Asthenia—Prednisone—ankylosing spondylitis	0.00124	0.00234	CcSEcCtD
Methysergide—Pain—Methotrexate—ankylosing spondylitis	0.00123	0.00233	CcSEcCtD
Methysergide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00119	0.00224	CcSEcCtD
Methysergide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00118	0.00223	CcSEcCtD
Methysergide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00118	0.00223	CcSEcCtD
Methysergide—Nausea—Betamethasone—ankylosing spondylitis	0.00118	0.00222	CcSEcCtD
Methysergide—Nausea—Dexamethasone—ankylosing spondylitis	0.00118	0.00222	CcSEcCtD
Methysergide—Dizziness—Prednisone—ankylosing spondylitis	0.00114	0.00215	CcSEcCtD
Methysergide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00114	0.00215	CcSEcCtD
Methysergide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00114	0.00215	CcSEcCtD
Methysergide—Vomiting—Prednisone—ankylosing spondylitis	0.0011	0.00207	CcSEcCtD
Methysergide—Rash—Prednisone—ankylosing spondylitis	0.00109	0.00205	CcSEcCtD
Methysergide—Dermatitis—Prednisone—ankylosing spondylitis	0.00109	0.00205	CcSEcCtD
Methysergide—Asthenia—Methotrexate—ankylosing spondylitis	0.00104	0.00195	CcSEcCtD
Methysergide—Nausea—Prednisone—ankylosing spondylitis	0.00103	0.00193	CcSEcCtD
Methysergide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000987	0.00186	CcSEcCtD
Methysergide—Dizziness—Methotrexate—ankylosing spondylitis	0.000954	0.0018	CcSEcCtD
Methysergide—Vomiting—Methotrexate—ankylosing spondylitis	0.000918	0.00173	CcSEcCtD
Methysergide—Rash—Methotrexate—ankylosing spondylitis	0.00091	0.00172	CcSEcCtD
Methysergide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000909	0.00171	CcSEcCtD
Methysergide—Nausea—Methotrexate—ankylosing spondylitis	0.000857	0.00162	CcSEcCtD
